General Information
Drug ID
DR00174
Drug Name
Tenofovir
Synonyms
(R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-9-(2-Phosphonylmethoxypropyl)adenine; (R)-PMPA; Apropovir; D,L-Tenofovir; GNA & Tenofovir; GS 1275; GS 1278; GS1278; HHA & Tenofovir; KS-5021; PMPA; PMPA-(R); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-& Hippeastrum hybrid agglutinin(HHA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-(9CI); Phosphonic acid, [[2-(6-amino-9H-purin-9; TDF; TFV; Tenefovir; Viread (TN); Viread, Tenofovir; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD11: 1C62.Z] Approved [1]
Therapeutic Class
Anti-HIV Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=464205"></iframe>
3D MOL 2D MOL
Formula
C9H14N5O4P
Canonical SMILES
CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O
InChI
InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1
InChIKey
SGOIRFVFHAKUTI-ZCFIWIBFSA-N
CAS Number
CAS 147127-20-6
Pharmaceutical Properties Molecular Weight 287.216 Topological Polar Surface Area 136
Heavy Atom Count 19 Rotatable Bond Count 5
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 8
XLogP
-1.6
PubChem CID
464205
PubChem SID
102979961 , 10304546 , 103169192 , 109738216 , 12014981 , 121362228 , 124757224 , 125164028 , 126610616 , 126628295 , 126655803 , 127310209 , 127310210 , 127339001 , 127339002 , 129233080 , 134337989 , 135078595 , 135606020 , 135611180 , 135682533 , 135698226 , 136367764 , 136372374 , 136905481 , 137005935 , 141613622 , 14873257 , 151996120 , 152034360 , 152165365 , 152246774 , 152344570 , 160963648 , 162184452 , 162793588 , 163658367 , 163813066 , 171563543 , 3727050 , 3727057 , 46508131 , 48424314 , 50112788 , 50437671 , 57405565 , 610434 , 7980754 , 92719253 , 99437132
ChEBI ID
CHEBI:63625
TTD Drug ID
D0D9HW
DT(s) Transporting This Drug BCRP Transporter Info Breast cancer resistance protein Substrate [2]
MRP4 Transporter Info Multidrug resistance-associated protein 4 Substrate [3]
MRP7 Transporter Info Multidrug resistance-associated protein 7 Substrate [4]
MRP8 Transporter Info Multidrug resistance-associated protein 8 Substrate [5]
OAT1 Transporter Info Organic anion transporter 1 Substrate [6]
OAT3 Transporter Info Organic anion transporter 3 Substrate [7]
P-GP Transporter Info P-glycoprotein 1 Substrate [8]
Drug-Transporter Activity Data
Drug-Transporter Activity Data OAT1 Transporter Info Km = 33.8 microM Chinese hamster ovary (CHO) cells-OAT1 [6]
OAT3 Transporter Info Km = 770 microM BHK-21 cells-OAT3 [9]
References
1 Tenofovir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01913)
3 Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol Pharmacol. 2007 Feb;71(2):619-27.
4 Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction. J Infect Dis. 2011 Jul 1;204(1):145-53.
5 Tenofovir Disoproxil Fumarate Is a New Substrate of ATP-Binding Cassette Subfamily C Member 11. Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e01725-16.
6 Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs. Nucleosides Nucleotides Nucleic Acids. 2001 Apr-Jul;20(4-7):641-8.
7 Tenofovir alafenamide is not a substrate for renal organic anion transporters (OATs) and does not exhibit OAT-dependent cytotoxicity. Antivir Ther. 2014;19(7):687-92.
8 KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01665)
9 Novel nucleotide human immunodeficiency virus reverse transcriptase inhibitor GS-9148 with a low nephrotoxic potential: characterization of renal transport and accumulation. Antimicrob Agents Chemother. 2009 Jan;53(1):150-6.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.